Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Alumis stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALMS.
You can purchase shares of Alumis (NASDAQ:ALMS) through any online brokerage.
Other companies in Alumis’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Third Harmonic Bio (NASDAQ:THRD), SNDL (NASDAQ:SNDL) and Bioage Labs (NASDAQ:BIOA).
Alumis has a consensus price target of $28.00.
The stock price for Alumis (NASDAQ: ALMS) is $4.97 last updated April 22, 2025 at 4:00 PM EDT.
There are no upcoming dividends for Alumis.
Alumis’s Q1 earnings are confirmed for Thursday, May 15, 2025.
There is no upcoming split for Alumis.
Alumis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.